FDA approves Roche’s Xofluza to prevent influenza following contact with infected person

This article was originally published here

The regulator has approved the company’s supplemental new drug application (sNDA) for Xofluza for the prevention of influenza in people aged 12 years and older following contact with

The post FDA approves Roche’s Xofluza to prevent influenza following contact with infected person appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply